表紙
市場調査レポート

世界のバイオインプラント市場(種類、地域別)-規模、シェア、世界動向、企業プロファイル、需要、動向、分析、調査、報告、機会、セグメンテーションと将来予測

Global Bio-implants Market (Types, and geography) - Size, Share, Global Trends, Company Profiles, Demand, Insights, Analysis, Research, Report, Opportunities, Segmentation and Forecast, 2013 - 2020

発行 Allied Market Research 商品コード 318267
出版日 ページ情報 英文 140 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=102.12円で換算しております。
Back to Top
世界のバイオインプラント市場(種類、地域別)-規模、シェア、世界動向、企業プロファイル、需要、動向、分析、調査、報告、機会、セグメンテーションと将来予測 Global Bio-implants Market (Types, and geography) - Size, Share, Global Trends, Company Profiles, Demand, Insights, Analysis, Research, Report, Opportunities, Segmentation and Forecast, 2013 - 2020
出版日: 2014年10月14日 ページ情報: 英文 140 Pages
概要

バイオインプラントは心血管、歯科、整形外科、眼科、神経疾患など様々な症状に対する有望な解決策として注目されています。世界のバイオインプラント市場は2020年までに1,158億米ドルに達すると予測され、2014〜2020年のCAGRは10.3%となっています。心血管疾患、整形外科疾患、脊椎障害などの罹患率の上昇がバイオインプラント市場を牽引する主な要因となっています。

当レポートでは、世界のバイオインプラント市場について分析し、製品別の動向、将来的見通し、地域別動向、および参入企業のプロファイルなどをまとめています。

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 世界のバイオインプラント市場概要

  • 市場の定義と範囲
  • 主な調査結果
  • ナノシートバイオマテリアル:創傷治癒の新たなアプローチ
  • 脳研究における変革
  • バイオインプラントに用いられるバイオマテリアル
  • ポーターズファイブフォース分析
  • バリューチェーン分析
  • 政府の規制
  • 市場シェア分析
  • 市場動向

第4章 世界のバイオインプラント市場:種類別

  • 心血管
  • 歯科・美容インプラント
  • 整形外科/関節再建・置換バイオインプラント
  • 脊椎バイオインプラント
  • 眼科バイオインプラント
  • その他

第5章 地域別

  • 北米
  • アジア太平洋地域
  • LAMEA
  • その他

第6章 欧州のバイオインプラント市場分析

  • 市場動向
  • 市場規模と予測
  • 政府の規制
  • ドイツ
  • フランス
  • 英国
  • オランダ
  • その他の諸国
  • 地域別企業分析

第7章 企業プロファイル

  • DENTSPLY International
  • Wright Medical Group
  • Invibio Biomaterial Solutions
  • BIOMET (Zimmer)
  • Medtronic, Inc.
  • Stryker Corporation
  • Smith & Nephews
  • DePuy Synthes
  • Ethicon Inc.
  • KLS Martin
目次
Product Code: ME 14576

Bio-implants have emerged as a promising solution for the variety of conditions such as cardiovascular, dental, orthopedic, ophthalmology, neurological disorders and others. Global bio implants market is forecast to reach $115.8 billion by 2020, registering a CAGR of 10.3% from 2014 to 2020. High prevalence of disease conditions such as cardiovascular, orthopedic and spinal disorders that can be treated via bio implants are the key drivers of the bio implants market. According to American College Of Surgeons, 29% of the trauma injuries were caused by road accidents; the instances of road accidents and death due to the same are rising to about 2.2% globally. Such patients undergoing traumatic injuries can be effectively treated with bio implants. Such afore-mentioned factor and multifarious analogous factors across cardiovascular, spinal and ophthalmic disorders drive the growth of the bio implants market.

The global bio-implants market is segmented based on product types and geography. Within the product types, the bio implants market is segmented into cardiovascular, dental and prosthetic implants, orthopedic/joint reconstruction and replacement bio implants, spinal bio implants, ophthalmology bio implants and others. Geographically, the market is segmented into four regions, namely North America, Europe, Asia-Pacific and LAMEA.

Key players operating in the global bio implants market focus on product launch, and continual R&D on variants of bio implants in order to retain competitive advantage. These players also adopt inorganic growth strategy to augment geographical diversification. Few of such companies mentioned in the report are Stryker Corporation, Dentsply international, Ethicon Inc., Wright Medical Group, DePuy Synthes, Biomet (Zimmer), Smith & Nephew, KLS martin and Medtronic.

Key Benefits

  • An in-depth analysis of the current bio-implants market scenario in order to estimate future market and to provide trend-analysis that would facilitate decision making
  • Quantitative analysis of the current market and estimations through 2013-2020 would assist strategy officials to design business strategies intended to capitalize on opportunities in the market
  • Identification of key product segments based on current and potential growth prospects to reveal most profitable segments that can be catered to by the market players
  • Analysis of business models, SWOT analysis and key strategies adopted by few leading market players to reveal insights on competitive analysis scenario

Key Market Segments

Market by Product Types

  • Cardiovascular bio-implants
    • Stents
    • Pacing devices
    • Others
  • Dental and Prosthetic bio-implants
  • Orthopedic/joint reconstruction and replacement bio-implants
    • Orthobiologics
    • Trauma Implants
    • Sport Medicines
  • Spinal bio-implants
    • Thoracolumber implants
    • Interverteberal spacers
    • Machined Allograft Spacers
    • Motion Preservation implants
    • Implantable spinal stimulators
  • Ophthalmology bio-implants
    • Glaucoma Implants
    • Intraocular Implants
  • Other bio-implants

Market by Geography

  • North America
    • Europe
    • France
    • Germany
    • U.K.
    • Others
  • Asia-Pacific
  • LAMEA

Table of Contents

CHAPTER 1 - INTRODUCTION

  • 1.1. Report Description
  • 1.2. Reason for doing the study
  • 1.3. Key Benefits
  • 1.4. Key Market Segments
  • 1.5. Key Audiences
  • 1.6. Research Methodology
    • 1.6.1. Secondary Research
    • 1.6.2. Primary Research
    • 1.6.3. Analyst tools and models

CHAPTER 2 - EXECUTIVE SUMMARY

  • 2.1. CXO perspective
  • 2.2. Market beyond: what to expect by 2025
    • 2.2.1. Moderate growth scenario, (2020-2025)
    • 2.2.2. Rapid growth scenario, (2020-2025)
    • 2.2.3. Diminishing growth scenario, (2020-2025)

CHAPTER 3 - GLOBAL BIOIMPLANTS MARKET OVERVIEW

  • 3.1. Market Definition and Scope
  • 3.2. Key findings
    • 3.2.1. Top Factors Impacting Global Bio implant Market
    • 3.2.2. Top Winning Strategies in Global Bio implant Market
    • 3.2.3. Top Investment Pockets of Global Bio implant Market
  • 3.3. Nanosheet Biomaterials: Novel approach for wound healing
  • 3.4. Transformation in Brain studies: 3D Brain-like tissues
  • 3.5. Biomaterial used in bioimplants (Comparison)
  • 3.6. Porter's five forces analysis
    • 3.6.1. Bargaining power of Suppliers
    • 3.6.2. Bargaining power of buyers
    • 3.6.3. Threats from substitute products
    • 3.6.4. Threat from new entrants
    • 3.6.5. Industry rivalry
  • 3.7. Value Chain analysis
  • 3.8. Government Regulations
  • 3.9. Market share analysis,2013
  • 3.10. Market Dynamics
    • 3.10.1. Drivers
      • 3.10.1.1. Technological advancement
      • 3.10.1.2. Rising incidence of trauma injuries
      • 3.10.1.3. Increasing government initiatives
      • 3.10.1.4. Growing elderly population
    • 3.10.2. Restraints
      • 3.10.2.1. Instability of bio Implants
      • 3.10.2.2. Corrosion of bio implant
      • 3.10.2.3. Increasing Price Competition and deterioration of material quality
    • 3.10.3. Opportunities
      • 3.10.3.1. Novel bio implants
      • 3.10.3.2. evolution in bio implants

CHAPTER 4 - GLOBAL BIO IMPLANTS MARKET BY TYPES

  • 4.1. Cardiovascular
    • 4.1.1. Market size and forecast
    • 4.1.2. Stents
    • 4.1.3. Pacing Devices
      • 4.1.3.1. Implantable Cardiac Defibrillators (ICD) applications
    • 4.1.4. Others
      • 4.1.4.1. Heart Valves
      • 4.1.4.2. Catheters
      • 4.1.4.3. Vascular Grafts
      • 4.1.4.4. Guidewires
      • 4.1.4.5. Wireless Sensors
  • 4.2. Dental and Prosthetic Implants
    • 4.2.1. Market size and forecast
    • 4.2.2. Plate form dental implants
    • 4.2.3. Root form dental implants
  • 4.3. Orthopedic/Joint Reconstruction and Replacement bio implants
    • 4.3.1. Market size and forecast
    • 4.3.2. Orthobiologics
    • 4.3.3. Trauma Implants
    • 4.3.4. Sport Medicines
    • 4.3.5. Joint Replacement Bio implants
      • 4.3.5.1. Knee Replacement Bioimplants
      • 4.3.5.2. Hip Replacement Bioimplants
    • 4.3.6. Wound Healing
    • 4.3.7. Market size and forecast
    • 4.3.8. Fracture Fixation Devices
      • 4.3.8.1. Sutures and Staples
  • 4.4. Spinal Bio implants
    • 4.4.1. Thoracolumber implants
    • 4.4.2. Interverteberal spacers
    • 4.4.3. Machined Allograft Spacers
    • 4.4.4. Motion Preservation implants
    • 4.4.5. Implantable spinal stimulators
  • 4.5. Ophthalmology Bio implants
    • 4.5.1. Market size and forecast
    • 4.5.2. Glaucoma Implants
    • 4.5.3. Intraocular Implants
  • 4.6. Others
    • 4.6.1. Tissue Engineering
      • 4.6.1.1. Growth Factors
      • 4.6.1.2. Stem Cell Therapy
      • 4.6.1.3. Nanomaterials For Tissue Engineering
      • 4.6.1.4. Nanoparticles
      • 4.6.1.5. Nanoscaffolds
    • 4.6.2. Neurological disorders
    • 4.6.3. Market size and forecast

CHAPTER 5 - GLOBAL BIO IMPLANTS MARKET BY GEOGRAPHY

  • 5.1. North America
    • 5.1.1. Key Market Trends
    • 5.1.2. Competitive Scenario
    • 5.1.3. Key Growth Factors and Opportunities
    • 5.1.4. Market size and Forecast
  • 5.2. Asia Pacific
    • 5.2.1. Key Market Trends
    • 5.2.2. Competitive Scenario
    • 5.2.3. Key Growth Factors and Opportunities
    • 5.2.4. Market size and Forecast
  • 5.3. LAMEA
    • 5.3.1. Key Market Trends
    • 5.3.2. Key Growth Factors and Opportunities
    • 5.3.3. Market size and Forecast

CHAPTER 6 - EUROPEAN BIO IMPLANTS MARKET ANALYSIS

  • 6.1. Market Dynamics
    • 6.1.1. Drivers
      • 6.1.1.1. High Prevalence of lifestyle diseases
      • 6.1.1.2. lucrative medical tourism destination
      • 6.1.1.3. Growing aging population
    • 6.1.2. Restraints
      • 6.1.2.1. Government Regulations
      • 6.1.2.2. Increasing Price Competition
  • 6.2. Key Market Trends
    • 6.2.1. Market size and forecast
  • 6.3. Government Regulations
  • 6.4. Germany Bioimplants market, 2013-2020, $million
  • 6.5. France Bioimplants market, 2013-2020, $million
  • 6.6. The United Kingdom Bioimplants market, 2013-2020, $million
  • 6.7. The Netherlands bio implants market, 2013-2020, $million
  • 6.8. Bioimplants market in other European countries, 2013-2020, $million
  • 6.9. Company analysis by region
    • 6.9.1. Germany
      • 6.9.1.1. Biotronik
        • 6.9.1.1.1. COMPANY OVERVIEW
        • 6.9.1.1.2. RECENT DEVELOPMENTS
      • 6.9.1.2. B.Braun
        • 6.9.1.2.1. COMPANY OVERVIEW
    • 6.9.2. France
      • 6.9.2.1. SBM (Science for Biomaterials)
        • 6.9.2.1.1. COMPANY OVERVIEW
      • 6.9.2.2. kasios
        • 6.9.2.2.1. COMPANY OVERVIEW
    • 6.9.3. UK
      • 6.9.3.1. Smith & Nephew
        • 6.9.3.1.1. COMPANY OVERVIEW
        • 6.9.3.1.2. RECENT DEVELOPMENTS
      • 6.9.3.2. Mediplus
        • 6.9.3.2.1. COMPANY OVERVIEW

CHAPTER 7 - COMPANY PROFILE

  • 7.1. DENTSPLY International
    • 7.1.1. Company Overview
    • 7.1.2. Operating Segments
    • 7.1.3. Business Performance
    • 7.1.4. Strategic Move and Development
    • 7.1.5. SWOT Analysis of DENTSPLY International
  • 7.2. Wright Medical Group
    • 7.2.1. Company Overview
    • 7.2.2. Operating segments
    • 7.2.3. Business Performance
    • 7.2.4. Strategic Move and Development
    • 7.2.5. SWOT Analysis of Wright Medical Group
  • 7.3. Invibio Biomaterial Solutions
    • 7.3.1. Company Overview
    • 7.3.2. Operating Segments
    • 7.3.3. Strategic move and development
    • 7.3.4. SWOT Analysis of Invibio Biomaterial Solutions
  • 7.4. BIOMET (Zimmer)
    • 7.4.1. Company Overview
    • 7.4.2. Operating Segments
    • 7.4.3. Business Performance
    • 7.4.4. Strategic move and Development
    • 7.4.5. SWOT Analysis of BIOMET
  • 7.5. Medtronic, Inc.
    • 7.5.1. Company overview
    • 7.5.2. Operating segments
    • 7.5.3. Business performance
    • 7.5.4. Strategic moves and developments
    • 7.5.5. SWOT Analysis
  • 7.6. Stryker Corporation
    • 7.6.1. Company Overview
    • 7.6.2. Operating segments
    • 7.6.3. Business performance
    • 7.6.4. Strategic moves and developments
    • 7.6.5. SWOT Analysis
  • 7.7. Smith & Nephews
    • 7.7.1. Company Overview
    • 7.7.2. Operating segments
    • 7.7.3. Business Performance
    • 7.7.4. Strategic move and development
    • 7.7.5. SWOT Analysis of Smith and Nephew
  • 7.8. DePuy Synthes
    • 7.8.1. Company Overview
    • 7.8.2. DePuy Synthes Operating segments
    • 7.8.3. Business Performance
    • 7.8.4. Strategic move and development
    • 7.8.5. SWOT Analysis Of DePuy Synthes
  • 7.9. Ethicon Inc.
    • 7.9.1. Company Overview
    • 7.9.2. Operating segments
    • 7.9.3. Business Performance
    • 7.9.4. Strategic Moves and Development
    • 7.9.5. SWOT Analysis of Ethicon
  • 7.10. KLS Martin
    • 7.10.1. Company overview
    • 7.10.2. Operating segments
    • 7.10.3. Strategic move and development
    • 7.10.4. SWOT Analysis of KLS Martin

List of Tables

  • TABLE 1: BIOMATERIAL COMPARISON WITH EXAMPLES
  • TABLE 2: BIOMATERIALS CHARACTERISTICS
  • TABLE 3: INCIDENT OF MECHANICAL TRAUMATIC INJURIES IN USA (2013)
  • TABLE 4: TRAUMA INJURY FACILITIES BY REGION
  • TABLE 5: TOP 10 COUNTRIES HEALTHCARE EXPENDITURE 2013
  • TABLE 6: POPULATION STATISTICS OF 2013, BY AGE AND SEX (THOUSANDS)
  • TABLE 7: ADVERSE REACTIONS REPORTED WITH DENTAL MATERIALS IN UK
  • TABLE 8: GLOBAL BIO IMPLANTS MARKET REVENUE BY APPLICATION, 2013-2020 ($MILLION)
  • TABLE 9: CARDIOVASCULAR IMPLANTS
  • TABLE 10: GLOBAL CARDIOVASCULAR BIO IMPLANT MARKET REVENUE BY TYPES, 2013 - 2020 ($MILLION)
  • TABLE 11: GLOBAL CARDIOVASCULAR BIO IMPLANT MARKET REVENUE BY GEOGRAPHY, 2013 - 2020 ($MILLION)
  • TABLE 12: GLOBAL CARDIOVASCULAR STENT BIO IMPLANTS MARKET REVENUE BY GEOGRAPHY, 2013 - 2020 ($MILLION)
  • TABLE 13: GLOBAL OTHER CARDIOVASCULAR BIO IMPLANTS MARKET REVENUE BY GEOGRAPHY, 2013 - 2020 ($MILLION)
  • TABLE 14: GLOBAL DENTAL BIO IMPLANTS MARKET REVENUE BY GEOGRAPHY, 2013 - 2020 ($MILLION)
  • TABLE 15: BIO IMPLANTS ORTHOPEDIC IMPLANTS
  • TABLE 16: MARKET PLAYERS IN ORTHOPEDIC IMPLANTS
  • TABLE 17: GLOBAL ORTHOPEDIC/JOINT RECONSTRUCTION AND REPLACEMENT BIO IMPLANTS BIO IMPLANTS MARKET REVENUE BY TYPES, 2013 - 2020 ($MILLION)
  • TABLE 18: GLOBAL ORTHOPEDIC/JOINT RECONSTRUCTION AND REPLACEMENT BIO IMPLANTS BIO IMPLANTS MARKET REVENUE BY GEOGRAPHY, 2013 - 2020 ($MILLION)
  • TABLE 19: BIO IMPLANTS USED IN WOUND DRESSINGS
  • TABLE 20: GLOBAL SPINAL BIO IMPLANTS MARKET REVENUE BY TYPE, 2013 - 2020 ($MILLION)
  • TABLE 21: GLOBAL SPINAL BIO IMPLANTS MARKET REVENUE BY GEOGRAPHY, 2013 - 2020 ($MILLION)
  • TABLE 22: GLOBAL THORACOLUMBER IMPLANTS MARKET REVENUE BY GEOGRAPHY, 2013 - 2020 ($MILLION)
  • TABLE 23: GLOBAL INTERVERTEBERAL SPACERS MARKET REVENUE BY GEOGRAPHY, 2013 - 2020 ($MILLION)
  • TABLE 24: GLOBAL MACHINED ALLOGRAFT SPACERS MARKET REVENUE BY GEOGRAPHY, 2013 - 2020 ($MILLION)
  • TABLE 25: GLOBAL MOTION PRESERVATION IMPLANTS MARKET REVENUE BY GEOGRAPHY, 2013 - 2020 ($MILLION)
  • TABLE 26: GLOBAL IMPLANTABLE SPINAL STIMULATORS MARKET REVENUE BY GEOGRAPHY, 2013 - 2020 ($MILLION)
  • TABLE 27: BIO IMPLANTS/DEVICES USED IN OPHTHALMOLOGY
  • TABLE 28: GLOBAL OPHTHALMOLOGY BIO IMPLANTS MARKET REVENUE BY TYPE, 2013 - 2020 ($MILLION)
  • TABLE 29: GLOBAL OPHTHALMOLOGY BIO IMPLANTS MARKET REVENUE BY GEOGRAPHY, 2013 - 2020 ($MILLION)
  • TABLE 30: GLOBAL OPHTHALMOLOGY BIO IMPLANTS MARKET REVENUE BY GEOGRAPHY, 2013 - 2020 ($MILLION)
  • TABLE 31: GLOBAL OPHTHALMOLOGY BIO IMPLANTS MARKET REVENUE BY GEOGRAPHY, 2013 - 2020 ($MILLION)
  • TABLE 32: BIO IMPLANT APPLICABLE AT DIFFERENT LEVEL TISSUE ENGINEERING
  • TABLE 33: GLOBAL OTHERS APPLICATION MARKET REVENUE BY GEOGRAPHY, 2013 - 2020 ($MILLION)
  • TABLE 34: NORTH AMERICA BIOIMPLANT MARKET REVENUE BY PRODUCT TYPES, 2013-2020 ($MILLION)
  • TABLE 35: ASIA-PACIFIC BIOIMPLANTS MARKET REVENUE BY PRODUCT TYPE, 2013-2020 ($MILLION)
  • TABLE 36: LAMEA BIOIMPLANTS MARKET REVENUE BY PRODUCT TYPES, 2013-2020 ($MILLION)
  • TABLE 37: POPULATION STATISTICS OF 2013, BY AGE AND SEX (THOUSANDS)
  • TABLE 38: EUROPEAN BIOIMPLANTS MARKET REVENUE BY PRODUCT TYPES, 2013-2020 ($MILLION)
  • TABLE 39: GERMANY BIO IMPLANT MARKET BY APPLICATION, 2013-2020, $MILLION
  • TABLE 40: FRANCE BIO IMPLANT MARKET BY APPLICATION, 2013-2020, $MILLION
  • TABLE 41: THE UNITED KINGDOM BIO IMPLANT MARKET BY APPLICATION, 2013-2020, $MILLION
  • TABLE 42: THE NETHERLANDS BIO IMPLANT MARKET BY APPLICATION, 2013-2020, $MILLION
  • TABLE 43: OTHER EUROPEAN COUNTRIES BIO IMPLANT MARKET BY APPLICATION, 2013-2020, $MILLION
  • TABLE 44: DENTSPLY SNAPSHOT
  • TABLE 45: DENTSPLY INTERNATIONAL OPERATING SEGMENTS
  • TABLE 46: REVENUE BY BUSINESS SEGMENT, 2013
  • TABLE 47: SWOT ANALYSIS OF DENTSPLY INTERNATIONAL
  • TABLE 48: WRIGHT MEDICAL GROUP SNAPSHOT
  • TABLE 49: WRIGHT MEDICAL GROUP OPERATING SEGMENTS
  • TABLE 50: REVENUE BY BUSINESS SEGMENT (2013)
  • TABLE 51: REVENUE BY GEOGRAPHY (2013)
  • TABLE 52: SWOT ANALYSIS OF WRIGHT MEDICAL GROUP
  • TABLE 53: INVIBIO BIOMATERIAL SOLUTIONS SNAPSHOT
  • TABLE 54: INVIBIO BIOMATERIAL SOLUTIONS OPERATING SEGMENTS
  • TABLE 55: SWOT ANALYSIS OF INVIBIO BIOMATERIAL SOLUTIONS
  • TABLE 56: BIOMET (ZIMMER) SNAPSHOT
  • TABLE 57: BIOMET (ZIMMER) OPERATING SEGMENTS
  • TABLE 58: SWOT ANALYSIS OF BIOMET (ZIMMER)
  • TABLE 59: MEDTRONIC SNAPSHOT
  • TABLE 60: MEDTRONIC OPERATING SEGMENTS
  • TABLE 61: STRYKER CORPORATION SNAPSHOT
  • TABLE 62: SMITH & NEPHEW SNAPSHOT
  • TABLE 63: SMITH & NEPHEW OPERATING SEGEMENTS
  • TABLE 64: DEPUY SYNTHES SNAPSHOT
  • TABLE 65: DEPUY SYNTHES OPERATING SYSTEM
  • TABLE 66: ETHICON SNAPSHOT
  • TABLE 67: ETHICON OPERATING SEGMENTS
  • TABLE 68: KLS MARTIN SNAPSHOT
  • TABLE 69: KLS MARTIN OPERATING SEGMENTS

List of Figures

  • FIG. 1: IMPACT ANALYSIS OF MODERATE GROWTH SCENARIO (2020-2025)
  • FIG. 2: IMPACT ANALYSIS OF RAPID GROWTH SCENARIO (2020-2025)
  • FIG. 3: IMPACT ANALYSIS OF DIMINISHING GROWTH SCENARIO (2020-2025)
  • FIG. 4: TOP FACTORS IMPACTING GLOBAL BIO IMPLANTS MARKET, 2013-2020
  • FIG. 5: TOP WINNING STRATEGIES IN GLOBAL BIO IMPLANTS MARKET 2011-2014
  • FIG. 6: TOP WINNING STRATEGIES IN GLOBAL BIO IMPLANTS MARKET, 2011-2014
  • FIG. 7: TOP INVESTMENT POCKETS OF GLOBAL BIO IMPLANTS MARKET
  • FIG. 8: PORTER'S FIVE FORCE MODEL OF BIO IMPLANTS MARKET
  • FIG. 9: VALUE CHAIN ANALYSIS OF BIO IMPLANTS MARKET
  • FIG. 10: AVERAGE APPROVAL TIME FOR DIFFERENT CLASSES OF MEDICAL DEVICE IN LEADING MARKETS IN 2013
  • FIG. 11: MARKET SHARE ANALYSIS OF BIO IMPLANTS MARKET 2013
  • FIG. 12: REVENUE BY BUSINESS SEGMENT, 2013
  • FIG. 13: REVENUE BY GEOGRAPHY,2013
  • FIG. 14: REVENUE BY GEOGRAPHY(2013)
  • FIG. 15: REVENUE BY BUSINESS SEGMENTS (2013)
  • FIG. 16: SWOT ANALYSIS OF MEDTRONIC
  • FIG. 17: REVENUE BY GEOGRAPHY(2013)
  • FIG. 18: REVENUE BY BUSINESS SEGMENTS (2013)
  • FIG. 19: SWOT ANALYSIS OF STRYKER CORPORATION
  • FIG. 20: SMITH & NEPHEWS REVENUE BY BUSINESS SEGMENTS,2013
  • FIG. 21: SMITH & NEPHEWS REVENUE BY GEOGRAPHY, 2013
  • FIG. 22: SWOT ANALYSIS OF SMITH AND NEPHEW
  • FIG. 23: SWOT ANALYSIS OF DEPUY SYNTHES
  • FIG. 24: REVENUE BY GEOGRAPHY (2013)
  • FIG. 25: REVENUE BY BUSINESS SEGMENT (2013)
  • FIG. 26: SWOT ANALYSIS OF ETHICON
  • FIG. 27: SWOT ANALYSIS OF KLS MARTIN
Back to Top